- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2190-9172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Systemic Treatment of Psoriasis with JAK Inhibitors: A Review ; volume:10 ; number:1 ; day:31 ; month:12 ; year:2019 ; pages:29-42 ; date:2.2020
Dermatology and therapy ; 10, Heft 1 (31.12.2019), 29-42, 2.2020
- Creator
-
Kvist-Hansen, Amanda
Hansen, Peter Riis
Skov, Lone
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13555-019-00347-w
- URN
-
urn:nbn:de:101:1-2020050221193642741778
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kvist-Hansen, Amanda
- Hansen, Peter Riis
- Skov, Lone
- SpringerLink (Online service)
Other Objects (12)
Systemic Treatment of Pediatric Psoriasis: A Review
Efficacy and safety of JAK inhibitors in the treatment of psoriasis and psoriatic arthritis: a systematic review and meta-analysis
Treatment of psoriasis
Janus Kinase Inhibitors as Successful Treatment Alternative in Dupilumab-Induced Psoriasis
Hemmung des JAK/STAT3-Pathways mit JAK-Inhibitoren in Mammakarzinomen
Effect of Age of Onset of Psoriasis on Clinical Outcomes with Systemic Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Synthesis of pan-JAK Inhibitor PF-06263276
Stellenwert der JAK-Inhibitoren („small is beautiful“)
JAK Inhibitors for Myelofibrosis: Strengths and Limitations
JAK-Inhibitoren für die Behandlung hämatoonkologischer Erkrankungen
Psoriasis-Arthritis – Was tun, wenn bei Psoriasis-Arthritis TNF-α-Inhibitoren nicht greifen?
Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast
Systemic Treatment of Pediatric Psoriasis: A Review
Efficacy and safety of JAK inhibitors in the treatment of psoriasis and psoriatic arthritis: a systematic review and meta-analysis
Treatment of psoriasis
Janus Kinase Inhibitors as Successful Treatment Alternative in Dupilumab-Induced Psoriasis
Hemmung des JAK/STAT3-Pathways mit JAK-Inhibitoren in Mammakarzinomen
Effect of Age of Onset of Psoriasis on Clinical Outcomes with Systemic Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Synthesis of pan-JAK Inhibitor PF-06263276
Stellenwert der JAK-Inhibitoren („small is beautiful“)
JAK Inhibitors for Myelofibrosis: Strengths and Limitations
JAK-Inhibitoren für die Behandlung hämatoonkologischer Erkrankungen
Psoriasis-Arthritis – Was tun, wenn bei Psoriasis-Arthritis TNF-α-Inhibitoren nicht greifen?
Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast
Systemic Treatment of Pediatric Psoriasis: A Review
Efficacy and safety of JAK inhibitors in the treatment of psoriasis and psoriatic arthritis: a systematic review and meta-analysis
Treatment of psoriasis
Janus Kinase Inhibitors as Successful Treatment Alternative in Dupilumab-Induced Psoriasis
Hemmung des JAK/STAT3-Pathways mit JAK-Inhibitoren in Mammakarzinomen
Effect of Age of Onset of Psoriasis on Clinical Outcomes with Systemic Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Synthesis of pan-JAK Inhibitor PF-06263276
Stellenwert der JAK-Inhibitoren („small is beautiful“)
JAK Inhibitors for Myelofibrosis: Strengths and Limitations
JAK-Inhibitoren für die Behandlung hämatoonkologischer Erkrankungen
Psoriasis-Arthritis – Was tun, wenn bei Psoriasis-Arthritis TNF-α-Inhibitoren nicht greifen?